Home Diagnostics, Inc. (NASDAQ:HDIX), a leading manufacturer and
marketer of diabetes testing supplies, today announced that
TRUE2go™, the world’s smallest blood glucose meter, is now
available in a rainbow of new colors. With TRUE2go in Radiant Red,
Mystic Purple, Phantom Black and Blue Energy, users now can match
their blood glucose meter to their unique personality and
style.
TRUE2go in colors delivers the same state-of-the-art technology,
affordability, size and convenience that users have come to expect
while allowing people with diabetes to personalize their meter with
a choice of four colors. The new TRUE2go in colors will be
available in most retail locations at the same low price of $9.99
and use the company’s TRUEtest™ strips, which can save people with
diabetes an average of $400* per year on diabetes testing
supplies.
“At Home Diagnostics, were are committed to developing
affordable, high-quality testing supplies that are designed to fit
the diverse needs of people with diabetes and make it easy for them
to test accurately and quickly at home or on-the-go,” said Joe
Capper, president and CEO of Home Diagnostics. “In the same way
that consumers look for ways to customize cell phones and other
devices they use every day, our users have requested blood glucose
meters that allow them to show their personalities. TRUE2go in
colors offers our customers a greater selection of reliable,
reasonably-priced meters that also add a new element of
self-expression to the routine task of testing their blood glucose
levels.”
TRUE2go in colors will be available at retailers throughout the
country starting this month.
*Data on file with Home Diagnostics, Inc.
About TRUE2go
About the size of a quarter and small enough to fit in a pocket
or purse, TRUE2go attaches to the top of a vial of test strips and
offers patients the convenience of on-the-go testing to help them
better manage their diabetes. TRUE2go also features no-coding
technology and a small sample size that make it more convenient for
diabetics to test their blood glucose levels more often, allowing
for greater control of their diabetes.
The meter is compatible with Home Diagnostics’ TRUEtest™ test
strips featuring the company’s patent-pending, state-of-the-art
GoldSensor™ laser accuracy and TRUEfill™ beveled tip. These
advanced features ensure highly accurate test results and first
test success by allowing for greater sampling precision and
accuracy.
To provide affordable diabetes care products without sacrificing
quality, retailers including CVS, Rite Aid and Walgreens partner
with Home Diagnostics for store branded diabetes testing supplies.
Home Diagnostics products are covered by Medicare, Medicaid and
most third-party insurance providers.
About Home Diagnostics, Inc.
Based in Fort Lauderdale, Florida, Home Diagnostics, Inc.
(NASDAQ:HDIX) is a leading developer, manufacturer and marketer of
diabetes management products. Home Diagnostics, Inc. offers a
portfolio of high-quality blood glucose monitoring systems that
spans the spectrum of features and benefits to help every person
with diabetes better monitor and manage their disease. The Home
Diagnostics, Inc. product line includes TRUE2go™, TRUEresult®,
TRUEtrack®, TRUEbalance™, Sidekick®, TRUEread® and Prestige IQ®
blood glucose monitoring systems. The products are available in
more than 45,000 pharmacies throughout the U.S. Home Diagnostics is
the exclusive co-brand supplier of blood glucose monitoring systems
for leading pharmacies including CVS, Rite Aid and Walgreens, as
well as distributors such as AmerisourceBergen, Cardinal Health,
McKesson, Invacare and Liberty Medical. Home Diagnostics, Inc. was
named one of Forbes magazine’s “200 Best Small Companies” in 2008,
and in 2009 received several recognitions for the company’s TRUE2go
blood glucose meter, including a Medical Design Excellence Award
(MDEA) and a Gold Award in the Medical/Test Equipment category as
part of appliance DESIGN Magazine’s 22nd Annual Excellence in
Design (EID) Awards Competition. For more information please visit
www.homediagnostics.com.
Forward-Looking
Statements
The above statements include forward-looking statements and are
subject to risks and uncertainties. Forward-looking statements give
the Company’s current expectations and projections relating to its
financial condition, results of operations, plans, objectives,
future performance and business. The statements can be identified
by the fact that they do not relate strictly to historical or
current facts. These statements may include words such as
“anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,”
“believe” and other words and terms of similar meaning in
connection with any discussion of the timing or nature of future
operating or financial performance or other events.
All statements other than statements of historical facts
included in this release that address activities, events or
developments that we expect, believe or anticipate will or may
occur in the future are forward-looking statements.
These forward-looking statements are largely based on our
expectations and beliefs concerning future events, which reflect
estimates and assumptions made by the Company’s management. These
estimates and assumptions reflect the Company’s best judgment based
on currently known market conditions and other factors relating to
the Company’s operations and business environment, all of which are
difficult to predict and many of which are beyond its control.
Although the Company believes its estimates and assumptions to
be reasonable, they are inherently uncertain and involve a number
of risks and uncertainties that are beyond the Company’s control.
In addition, management’s assumptions about future events may prove
to be inaccurate. Management cautions all readers that the
forward-looking statements contained in this release are not
guarantees of future performance, and the Company cannot assure any
reader that those statements will be realized or the
forward-looking events and circumstances will occur. Actual results
may differ materially from those anticipated or implied in the
forward-looking statements due to the factors listed in the “Risk
factors” and “Management’s discussion and analysis of financial
condition and results of operations” sections contained in its
filings with the Securities and Exchange Commission. All
forward-looking statements speak only as of the date of this
release. The Company does not intend to publicly update or revise
any forward-looking statements as a result of new information,
future events or otherwise, except as required by law. These
cautionary statements qualify all forward-looking statements
attributable to the Company or persons acting on its behalf.
TRUE2go, TRUEresult, TRUEbalance, TRUEtrack, Sidekick, TRUEread,
Prestige IQ, TRUEfill and TRUEtest are trademarks of Home
Diagnostics, Inc. All other trademarks are property of their
respective owners.
[HDIX-F]
Photos/Multimedia Gallery Available:
http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6064254&lang=en
Home Diagnostics (MM) (NASDAQ:HDIX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Home Diagnostics (MM) (NASDAQ:HDIX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
